dexfenfluramine has been researched along with Disease Exacerbation in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antier, D; Bonnet, P; Eder, V; Hanton, G; Hyvelin, JM; Lemaire, MC; Rochefort, GY | 1 |
| Aurigemma, G; Douglas, PS; Erban, S; Kriegel, G; Phillips, RS; Riley, M; Wee, CC | 1 |
| Gottdiener, JS; Gwynne, JT; Tighe, JF; Weissman, NJ | 1 |
| Gwynne, JT; Panza, JA; Tighe, JF; Weissman, NJ | 1 |
| Anstrom, KJ; Crary, JL; Jollis, JG; Mast, ST; Ryan, T | 1 |
2 trial(s) available for dexfenfluramine and Disease Exacerbation
| Article | Year |
|---|---|
Prevalence of valvular-regurgitation associated with dexfenfluramine three to five months after discontinuation of treatment.
Topics: Adolescent; Adult; Aortic Valve Insufficiency; Delayed-Action Preparations; Dexfenfluramine; Disease Progression; Double-Blind Method; Echocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Observer Variation; Prevalence; Risk Factors; Safety; Serotonin Receptor Agonists | 1999 |
Natural history of valvular regurgitation 1 year after discontinuation of dexfenfluramine therapy. A randomized, double-blind, placebo-controlled trial.
Topics: Adult; Analysis of Variance; Aortic Valve Insufficiency; Appetite Depressants; Dexfenfluramine; Disease Progression; Double-Blind Method; Echocardiography, Doppler; Female; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Obesity; Placebos; Serotonin Receptor Agonists; Statistics, Nonparametric | 2001 |
3 other study(ies) available for dexfenfluramine and Disease Exacerbation
| Article | Year |
|---|---|
Dexfenfluramine does not worsen but moderates progression of chronic hypoxia-induced pulmonary hypertension.
Topics: Animals; Blood Pressure; Body Weight; Chronic Disease; Dexfenfluramine; Disease Progression; Female; Heart Valve Diseases; Hypertension, Pulmonary; Hypoxia; Lung; Myocardium; Organ Size; Rats; Rats, Wistar; Serotonin Receptor Agonists; Ultrasonography, Doppler; Ventricular Function, Left; Ventricular Function, Right; Weight Gain | 2006 |
Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication.
Topics: Adult; Appetite Depressants; Cohort Studies; Dexfenfluramine; Disease Progression; Echocardiography; Female; Fenfluramine; Follow-Up Studies; Heart Valve Diseases; Heart Valves; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Single-Blind Method; Statistics, Nonparametric | 1998 |
The progression of fenfluramine-associated valvular heart disease assessed by echocardiography.
Topics: Adult; Aortic Valve Insufficiency; Appetite Depressants; Cohort Studies; Dexfenfluramine; Disease Progression; Echocardiography, Doppler; Female; Fenfluramine; Humans; Male; Mitral Valve Insufficiency; Retrospective Studies; Serotonin Agents | 2001 |